Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Nvta Stock

Finance    Medium opportunity   

  

Track this trend
(Monitor this trend over time)
 12 Months
Average: 28.33%
Trend: declining
MOM change: -0.46%
 5 Years
Average: 9.83%
Trend: growing
MOM change: 2.97%

Latest forum discussions

We tracked 12 total in the last 3 months

... are enrolling now. Invitae / NVTA 30.39 6.6 -27...the genetic testing firm Invitae (NVTA), down 27.3%; and the... Duchenne muscular dystrophy. The stock has not recovered. Janus Henderson ... get that high. The stock is trading below $80 per ... potential upside for that stock” when it reports its Phase .... He says that the stock could jump if that data ...$55 price target on the stock, implying a more-than 175% ...
Published on 2021-09-04 in the PGEN forum
This discussion is in English.
..." is how many times a stock in ARKG has been hit ... what some of these broken stock charts look like in her... million shares now of NVTA and has been absolutely crushed in that stock. The stock gapped lower from... the very next day. The stock continues to be under pressure ... take a look at the stock chart. It's a complete ...
Published on 2021-11-24 in the Compugen Ltd. (CGEN) forum
This discussion is in English.
..." is how many times a stock in ARKG has been hit ... what some of these broken stock charts look like in her... million shares now of NVTA and has been absolutely crushed in that stock. The stock gapped lower from... the very next day. The stock continues to be under pressure ... take a look at the stock chart. It's a complete ...
Published on 2021-11-24 in the Compugen Ltd. (CGEN) forum
This discussion is in English.
... nearly 6 million shares of NVTA in ARKG and another 16... $17. On Nov. 8th, the stock gapped down into the low ... bought it with both hands. NVTA went sideways for about 5 ... this on just about every stock but CGEN. It's as ...
Published on 2021-11-23 in the Compugen Ltd. (CGEN) forum
This discussion is in English.
... nearly 6 million shares of NVTA in ARKG and another 16... $17. On Nov. 8th, the stock gapped down into the low ... bought it with both hands. NVTA went sideways for about 5 ... this on just about every stock but CGEN. It's as ...
Published on 2021-11-23 in the Compugen Ltd. (CGEN) forum
This discussion is in English.
... $800 million in cash and stock.The deal makes PacBio the ... of its fat wallet and stock price to make more acquisitions, ... of Sept. 30 and its stock, which closed Monday at $22.... testing company Invitae Corp. (NYSE: NVTA). That multi-year deal centered ...
Published on 2021-11-28 in the PACB forum
This discussion is in English.
... $800 million in cash and stock.The deal makes PacBio the ... of its fat wallet and stock price to make more acquisitions, ... of Sept. 30 and its stock, which closed Monday at $22.... testing company Invitae Corp. (NYSE: NVTA). That multi-year deal centered ...
Published on 2021-11-28 in the PACB forum
This discussion is in English.
@Bob Packer .... Just thinking out loud, but I think that while there were some "talks" between EXAS and NVTA, I'm thinking that the CEO at NVTA "leaked" those talks to the Media in an effort to put his company in play (given how the stock price has collapsed from a high of $61) when he felt that KC's bid wasnt enough to move the needle. Either way, I think that EXAS "walked".
Published on 2021-11-11 in the Exact Sciences Corporation (EXAS) forum
This discussion is in English.
@Bob Packer .... Just thinking out loud, but I think that while there were some "talks" between EXAS and NVTA, I'm thinking that the CEO at NVTA "leaked" those talks to the Media in an effort to put his company in play (given how the stock price has collapsed from a high of $61) when he felt that KC's bid wasnt enough to move the needle. Either way, I think that EXAS "walked".
Published on 2021-11-11 in the Exact Sciences Corporation (EXAS) forum
This discussion is in English.
... the genetic testing firm Invitae (NVTA), down 27.3%; and the... in September 2019. The stock is up 61.2% since ... Duchenne muscular dystrophy. The stock has not recovered.Janus Henderson ... get that high. The stock is trading below $80 per ... potential upside for that stock” when it reports its ....He says that the stock could jump if that data ...$55 price target on the stock, implying a more-than 175% ...
Published on 2021-09-04 in the GBT forum
This discussion is in English.
... the genetic testing firm Invitae (NVTA), down 27.3%; and the... in September 2019. The stock is up 61.2% since ... Duchenne muscular dystrophy. The stock has not recovered.Janus Henderson ... get that high. The stock is trading below $80 per ... potential upside for that stock” when it reports its ....He says that the stock could jump if that data ...$55 price target on the stock, implying a more-than 175% ...
Published on 2021-09-04 in the GBT forum
This discussion is in English.
I do wish they would comment on NVTA , either way. Certainly weighting on the stock price.
Published on 2021-10-06 in the Exact Sciences Corporation (EXAS) forum
This discussion is in English.
I do wish they would comment on NVTA , either way. Certainly weighting on the stock price.
Published on 2021-10-06 in the Exact Sciences Corporation (EXAS) forum
This discussion is in English.
... of millions at $37 per stock traded up to $45 broke... ? and disappointed with GNOM PACB NVTA & BNGO all trading great...
Published on 2021-09-30 in the Acacia Research Corporation (ACTG) forum
This discussion is in English.
... of millions at $37 per stock traded up to $45 broke... ? and disappointed with GNOM PACB NVTA & BNGO all trading great...
Published on 2021-09-30 in the Acacia Research Corporation (ACTG) forum
This discussion is in English.
Nearly all my recent superstar performers are of speculative or "pricey" nature. On average I am up 25% on these, which is amazing given that I only got into them recently as the technical picture improved (CGEN and POWI are not speculative buys and are not up as much. NVTA is up 27% for me and it is a pricy stock). This tells you how the market's view of risk has changed.
Published on 2021-10-28 in the Strategies forum
This discussion is in English.
Nearly all my recent superstar performers are of speculative or "pricey" nature. On average I am up 25% on these, which is amazing given that I only got into them recently as the technical picture improved (CGEN and POWI are not speculative buys and are not up as much. NVTA is up 27% for me and it is a pricy stock). This tells you how the market's view of risk has changed.
Published on 2021-10-28 in the Strategies forum
This discussion is in English.
... on par with the median stock. The one exception is ARKG... pure genomics like CRPS or NVTA, but even in PFE and...
Published on 2021-10-12 in the Strategies forum
This discussion is in English.
... on par with the median stock. The one exception is ARKG... pure genomics like CRPS or NVTA, but even in PFE and...
Published on 2021-10-12 in the Strategies forum
This discussion is in English.